FDA: Ophthalmic drugs and devices | ASCRS
thumbprint

FDA: Ophthalmic drugs and devices

ASCRS advocates to ensure our members and their patients have timely access to innovative drugs and devices and access to compounded medications.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.